Uterus Transplantation: Acceptability of the Procedure in Eligible Patients
NCT ID: NCT06799728
Last Updated: 2025-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
150 participants
OBSERVATIONAL
2021-04-05
2026-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor
NCT05726305
Acceptance of Uterus Transplantation
NCT03048396
Uterus Transplantation From Live Donor
NCT01844362
Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus
NCT03579550
Uterus Transplantation From Live Donors With Robotic Assisted Surgery - Gothenburg II
NCT02987023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The causes of AUFI can be classified in primary/congenital (Mayer-Rokitansky-Kuster-Hauser-MRKH syndrome, Complete insensitivity to androgens-CAIS) and secondary/acquired (Asherman syndrome, previous hysterectomy for benign/malignant gynecological pathologies).
This condition was considered without therapeutic options until a few years ago, when the first birth from living donor uterus transplant was obtained (Sweden, 2014)2.
There are many challenges to the transplantation of the uterus:
* Ethical, complex and evolving issues: first of all the acceptability by patients;3
* the definition of inclusion criteria for donors and recipients, based on the results of procedures carried out to date;4
* the presence of the donor: deceased or living, and in the latter the use of minimally invasive surgical techniques5.
Primary objective of the study Define the acceptability of the uterus transplant procedure in the target population through a cross-sectional observational study using a targeted questionnaire.
Secondary objective To assess the knowledge of certain aspects of uterine transplantation among the population affected by SVCD. To identify the opinion and needs of the study population.
Expected results The information will help improve the efficiency and quality of health services for people with SVD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with AUFI (MRKH, CAIS, previous hysterectomy due to benign/malignant/unfavorable obstetric outcome) and currently under treatment at the U.O.C. of Gynecology and Pathophysiology of Human Reproduction Polyclinic S. Orsola-Malpighi and registered with the Italian Association for Androgen Insensitivity and Similar Conditions-AISIA.
* Informed consent
* Networked electronic device ensuring connection to the platform and subsequent questionnaire filling
* Internet network
* Personal email address, to which the link for filling out the questionnaires will be sent
18 Years
44 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria C Meriggiola, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Bologna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Azienda Ospedaliero-Unioversitaria di Bologna
Bologna, Bologna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACCUTX-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.